Citation Impact
Citing Papers
Complement drives Th17 cell differentiation and triggers autoimmune arthritis
2010 StandoutNobel
Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility
2003 StandoutNobel
Endoscopic fluorescence detection of low and high grade dysplasia in Barrett's oesophagus using systemic or local 5-aminolaevulinic acid sensitisation
2001
Small Mannose-Binding Lectin-Associated Protein Plays a Regulatory Role in the Lectin Complement Pathway
2006
Side Effects and Photosensitization of Human Tissues after Aminolevulinic Acid
1997
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
2008 Standout
5‐Aminolevulinic Acid‐Based Photodynamic Therapy: Principles and Experimental Research
1997
Liver fibrosis
2005 Standout
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
2009 StandoutNature
Photodynamic Therapy
1998 Standout
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX
1996
The collectins in innate immunity
1996
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
2006 Standout
Congenital erythropoietic porphyria associated with myelodysplasia presenting in a 72-year-old man: report of a case and review of the literature
2003
Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease
1999
Function of the drosophila pattern-recognition receptor PGRP-SD in the detection of Gram-positive bacteria
2004 StandoutNobel
The present and future role of photodynamic therapy in cancer treatment
2004 Standout
Chronic viral hepatitis and the human genome
2000
Metronomic Photodynamic Therapy as a New Paradigm for Photodynamic Therapy: Rationale and Preclinical Evaluation of Technical Feasibility for Treating Malignant Brain Tumors¶
2004
Genetics of susceptibitlity to human infectious disease
2001
Homozygous hereditary C1q deficiency and systemic lupus erythematosus: A new family and the molecular basis of C1q deficiency in three families
1996
Two‐Photon Absorption and the Design of Two‐Photon Dyes
2009 Standout
Clinical Epidemiological Quality in Molecular Genetic Research
1999
Hereditary coproporphyria in Germany: clinical-biochemical studies in 53 patients
2000
Recognition of microorganisms and activation of the immune response
2007 StandoutNature
Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy
1993
Detection of Female Lower Genital Tract Dysplasia Using Orally Administered 5-Aminolevulinic Acid Induced Protoporphyrin IX: A Preliminary Study
2002
Guide to drug porphyrogenicity prediction and drug prescription in the acute porphyrias
2007
Isolation, Characterization, and Antimicrobial Properties of Bovine Oligosaccharide-binding Protein
2002
Monitoring ALA‐induced PpIX Photodynamic Therapy in the Rat Esophagus Using Fluorescence and Reflectance Spectroscopy
2008
Porphyrias
2010 Standout
Mechanisms of Actions of Inhaled Anesthetics
2003 Standout
Photodynamic therapy using 5-aminolevulinic acid for premalignant and malignant lesions of the oral cavity
1996
Photodynamic therapy for cancer
2003 Standout
Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinic acid
1999
Association of furunculosis and familial deficiency of mannose‐binding lectin
2005
Oxygen monitoring during 5-aminolaevulinic acid induced photodynamic therapy in normal rat colon
2000
Interstitial photodynamic therapy in the canine prostate with disulfonated aluminum phthalocyanine and 5-aminolevulinic acid-induced protoporphyrin IX
1997
Enhancement of photodynamic therapy with 5-aminolaevulinic acid-induced porphyrin photosensitisation in normal rat colon by threshold and light fractionation studies
1995
Photosensitizers in clinical PDT
2004
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results
2011 Standout
Methods for the preparation of chlorophyllide a: An intermediate of the chlorophyll biosynthetic pathway
2011 StandoutNobel
Photodynamic therapy in women with cervical intraepithelial neoplasia using topically applied 5-aminolevulinic acid
1999
Malignant Gliomas in Adults
2008 Standout
MBL genotype and risk of invasive pneumococcal disease: a case-control study
2002
Oncologic photodynamic therapy photosensitizers: A clinical review
2010
In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid
1998
Biosynthesis of chlorophylls from protoporphyrin IX
2003
A second serine protease associated with mannan-binding lectin that activates complement
1997 Nature
Photodynamic therapy in oncology
2001
Leprosy
2004 Standout
Complement
2001 Standout
Primary brain tumours in adults
2012 Standout
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
Innate immunity to malaria
2004
Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
1998 Standout
Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series
1997
A Dominant Complement Fixation Pathway for Pneumococcal Polysaccharides Initiated by SIGN-R1 Interacting with C1q
2006 StandoutNobel
The evolution and genetics of innate immunity
2001 StandoutNobel
Lectin complement system and pattern recognition
2006
Plasma levels of protoporphyrin IX in humans after oral administration of 5-aminolevulinic acid
1997
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
2007 Standout
Fluorescence-guided resection of glioblastoma multiforme utilizing 5-ALA-induced porphyrins: a prospective study in 52 consecutive patients
2000
Photodynamic therapy in dermatology
2000
Genetic polymorphisms in sepsis
2005
5-Aminolevulinic acid-based photodynamic therapy
1997
Intensive Insulin Therapy in the Medical ICU
2006 Standout
Evolution of the lectin–complement pathway and its role in innate immunity
2002
Photodynamic Therapy
1999
Toll-like receptors and innate immunity
2001 Standout
Photodynamic Therapy (PDT) and Photodiagnosis (PD) Using Endogenous Photosensitization Induced by 5-Aminolevulinic Acid (ALA): Mechanisms and Clinical Results
1996
RTP4 inhibits IFN-I response and enhances experimental cerebral malaria and neuropathology
2020 StandoutNobel
Metal Complexes as Photo- and Radiosensitizers
1999
Complement-related serine proteases in tunicates and vertebrates
1998
Intensive Insulin Therapy Exerts Antiinflammatory Effects in Critically Ill Patients and Counteracts the Adverse Effect of Low Mannose-Binding Lectin Levels
2003
Lectins: Carbohydrate-Specific Proteins That Mediate Cellular Recognition
1998 Standout
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Effect of Nitrous Oxide on Excitatory and Inhibitory Synaptic Transmission in Hippocampal Cultures
1998
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
In Vitro and In Vivo Efficacy of Photofrin® and Pheophorbide a, a Bacteriochlorin, in Photodynamic Therapy of Colonic Cancer Cells¶
2002
The cutaneous porphyrias: a review
1999
Nanoparticles in Photodynamic Therapy
2015 Standout
Early Exposure to Common Anesthetic Agents Causes Widespread Neurodegeneration in the Developing Rat Brain and Persistent Learning Deficits
2003 Standout
Cytokine Storm
2020 Standout
Mannose-Binding Lectin Polymorphisms in Patients with Hepatitis C Virus Infection
2000
BODIPY dyes in photodynamic therapy
2012 Standout
Collectins and collectin receptors in innate immunity
2000
Mannose-binding lectin: the pluripotent molecule of the innate immune system
1996
Chemistry of Biologically Important Synthetic Organoselenium Compounds
2001 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
A Common Dominant TLR5 Stop Codon Polymorphism Abolishes Flagellin Signaling and Is Associated with Susceptibility to Legionnaires' Disease
2003 StandoutNobel
Activatable Photosensitizers for Imaging and Therapy
2010 Standout
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
Emerging Targets in Photopharmacology
2016 StandoutNobel
Reversible Photochemical Control of Singlet Oxygen Generation Using Diarylethene Photochromic Switches
2014 StandoutNobel
Innate Immune Recognition
2002 Standout
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Intraoperative Detection of Malignant Gliomas by 5-Aminolevulinic Acid-induced Porphyrin Fluorescence
1998
Phylogenetic Perspectives in Innate Immunity
1999 StandoutScienceNobel
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D
1998
Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy
1995 Standout
Different Molecular Events Result in Low Protein Levels of Mannan-Binding Lectin in Populations from Southeast Africa and South America
1998
MANAGEMENT OF ACUTE AND CUTANEOUS PORPHYRIAS
2002
Works of A. Gorchein being referenced
Porphyrins in urine, plasma, erythrocytes, bile and faeces in a case of congenital erythropoietic porphyria (Gunther's disease) treated with blood transfusion and iron chelation: lack of benefit from oral charcoal
1998
Drug treatment in acute porphyria
1997
Sustained high plasma 5‐aminolaevulinic acid concentration in a volunteer: no porphyric symptoms
1992
Mannose binding protein gene mutations associated with unusual and severe infections in adults
1995
Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX--a pilot study.
1995
δ-Aminolaevulinic acid in plasma, cerebrospinal fluid, saliva and erythrocytes: Studies in normal, uraemic and porphyric subjects
1987
MEGALOBLASTIC HAEMOPOIESIS AFTER MULTIPLE SHORT-TERM EXPOSURE TO NITROUS OXIDE
1982
Uptake of protoporphyrin and continuous spectrophotometric assay for magnesium chelatase in Rhodobacter spheroides.
1994